This research provided results of migration and proliferation of human HCC SMMC-7721 cells and protein expression level on these cells after treating with the antibody, and found that Metuzumab could specifically bind to CD147, leading to secretion of MMP, and eventually result in a decrease in the invasive capacity of hepatoma cells. Here, BSG is linked to hepatocellular carcinoma.